Mirati
2 known investors
Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.
Investors Β· 2
Frequently asked questions
- What does Mirati do?
- Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.
- Who are Mirati's investors?
- Mirati's investors include Avoro Capital Advisors, BioBrit.